Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140848 · ClinicalTrials.gov registry record · NA
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
A NA study, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT07140848: Recruiting NA study, sponsored by State University of New York at Buffalo.
NCT07140848 is a NA study that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07140848, a NA study, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
Primary Outcome
Blood specimens (10 cc of blood) will be obtain by trained phlebotomists or nurse for HbA1c.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL CGM-DPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2026-04-13 |
| Est. Completion | 2028-03 |
| Phase | NA |
What NCT07140848 shows while recruiting
NCT07140848 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07140848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07140848 about?
NCT07140848 is a clinical study titled "CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes". Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been show...
What is the current status of trial NCT07140848?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2026-04-13. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07140848?
The interventions under investigation include: Control (BEHAVIORAL), CGM-DPP (BEHAVIORAL).
Who is sponsoring clinical trial NCT07140848?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07140848's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI